Common Contracts

CROSS-LICENSE AGREEMENT

Cross-License Agreement • October 1st, 2024 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Cross-License Agreement
• Filed
  October 1st, 2024
• Company
  Seres Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This CROSS-LICENSE AGREEMENT (this “Agreement”), effective as of September 30, 2024 (the “Effective Date”), is made by and between Seres Therapeutics, Inc., a Delaware corporation (“Seller”), and Société des Produits Nestlé S.A., a société anonyme organized under the laws of Switzerland (“Purchaser”).

FORM OF CROSS-LICENSE AGREEMENT1

Cross-License Agreement • August 6th, 2024 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Cross-License Agreement
• Filed
  August 6th, 2024
• Company
  Seres Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Cross-License Agreement (this “Agreement”), effective as of [ ● ], 2024 (the “Effective Date”), is made by and between Seres Therapeutics, Inc., a Delaware corporation (“Seller”), and Société des Produits Nestlé S.A., a société anonyme organized under the laws of Switzerland (“Purchaser”).